Journal of the American Academy of Child & Adolescent Psychiatry
Volume 47, Issue 1 , Pages 61-67 , January 2008

Dopamine Transporter Genotype Conveys Familial Risk of Attention-Deficit/Hyperactivity Disorder Through Striatal Activation

,Accepted 31 July 2007.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 12.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 This work was supported by a Dutch Science Foundation VENI grant to Dr. Durston. The authors gratefully acknowledge all of the families who participated in this study; Nick Ramsey, Arjan van der Schaaf, and Bert Heesakkers for technical support; Bas Neggers, Erno Hermans, Matthijs Vink, and Martijn van der Heuvel for SPM2 support; and the clinical team at the Disruptive Disorders Clinic for their help in subject recruitment.

 Clinical trial registration information-URL: http://www.clinicaltrials.gov. Unique identifier: NCT00143832.

 Disclosure: The authors report no conflicts of interest

PII: S0890-8567(09)62085-2

doi: 10.1097/chi.0b013e31815a5f17

Journal of the American Academy of Child & Adolescent Psychiatry
Volume 47, Issue 1 , Pages 61-67 , January 2008

Article Tools

* Image Usage & Resolution